Literature DB >> 14967351

Ovarian function preservation in the cancer patient.

Tommaso Falcone1, Marjan Attaran, Mohamed A Bedaiwy, Jeffery M Goldberg.   

Abstract

OBJECTIVE: To review the clinical modalities that are available to women receiving potentially sterilizing cancer therapy.
DESIGN: The MEDLINE database was reviewed for all publications on medication, surgery, or assisted reproductive technology that could potentially preserve fertility in women who are receiving cancer therapy. CONCLUSION(S): There are many options available to a patient undergoing a treatment that will negatively impact her fertility. Many procedures and medical interventions have been proven successful both in terms of ovarian function and pregnancy rates. Other techniques have great potential but do not have long-term clinical data. It is important that the patient's primary care physician understand the methods available to preserve fertility in cancer patients and communicate this information to the patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14967351     DOI: 10.1016/j.fertnstert.2003.06.031

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  18 in total

Review 1.  Maintaining fertility in young women with breast cancer.

Authors:  Melissa C Hulvat; Jacqueline S Jeruss
Journal:  Curr Treat Options Oncol       Date:  2009-12

2.  Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries.

Authors:  Joanna Piasecka-Srader; Fernando F Blanco; Devora H Delman; Dan A Dixon; James L Geiser; Renata E Ciereszko; Brian K Petroff
Journal:  Biol Reprod       Date:  2015-04-01       Impact factor: 4.285

3.  Granulocyte colony-stimulating factor in conjunction with vascular endothelial growth factor maintains primordial follicle numbers in transplanted mouse ovaries.

Authors:  Malgorzata E Skaznik-Wikiel; Rakesh K Sharma; Kaisa Selesniemi; Ho-Joon Lee; Jonathan L Tilly; Tommaso Falcone
Journal:  Fertil Steril       Date:  2011-01-26       Impact factor: 7.329

Review 4.  Challenges and Potential for Ovarian Preservation with SERMs.

Authors:  Alison Y Ting; Brian K Petroff
Journal:  Biol Reprod       Date:  2015-03-25       Impact factor: 4.285

5.  Incorporating fertility preservation into the care of young oncology patients.

Authors:  Amanda J Redig; Robert Brannigan; Steven J Stryker; Teresa K Woodruff; Jacqueline S Jeruss
Journal:  Cancer       Date:  2011-01-01       Impact factor: 6.860

Review 6.  To transplant or not to transplant - that is the question.

Authors:  Sherman J Silber; Teresa K Woodruff; Lonnie D Shea
Journal:  Cancer Treat Res       Date:  2010

Review 7.  Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.

Authors:  Rodrigo R Munhoz; Allan A L Pereira; André D Sasse; Paulo M Hoff; Tiffany A Traina; Clifford A Hudis; Ricardo J Marques
Journal:  JAMA Oncol       Date:  2016-01       Impact factor: 31.777

Review 8.  Fertility preservation in patients receiving chemotherapy or radiotherapy.

Authors:  Randal D Robinson; Jennifer F Knudtson
Journal:  Mo Med       Date:  2014 Sep-Oct

9.  Fibrin-mediated delivery of an ovarian follicle pool in a mouse model of infertility.

Authors:  Rachel M Smith; Ariella Shikanov; Ekaterina Kniazeva; Deepa Ramadurai; Teresa K Woodruff; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2014-06-12       Impact factor: 3.845

Review 10.  Preservation of fertility in patients with cancer.

Authors:  Jacqueline S Jeruss; Teresa K Woodruff
Journal:  N Engl J Med       Date:  2009-02-26       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.